Emory Hospital

Atlanta, Georgia 30322

4 studies enrolling now · 27 studies all time

What they study most

Aortic Aneurysm, Abdominal, Aspergillosis, COVID-19, Clostridium Difficile Infection, Color Vision Defects, Coronary Artery Disease, Coronary Disease, Coronary Restenosis, Cystic Fibrosis, Diabetes Mellitus, Type 2, Essential Thrombocythemia, High Risk Essential Thrombocythemia

Studies at this site

• Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II — Recruiting now
• Mental Stress Reactivity in Women With CMD — Recruiting now
• Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease — Running, not enrolling
• A Screening and Recruitment Study in Adults Expressing Interest in the Emory Microbiota Enrichment Program — Paused
• Clinical Outcomes and Radiation Safety After Endovascular Repair of Complex AAAs Using Fenestrated- Branched Devices — Enrolling by invitation
• Subcutaneous Abatacept in Renal Transplant Recipients — Completed
• Precision Resuscitation With Crystalloids in Sepsis — Completed
• Comparison of Sepsis Prediction Algorithms — Starting soon
• Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial — Stopped early
• Green Hysteroscopy — Completed
• SomaSignal Tests on Medical Management and Change in Risk in Patients With Diabetes — Completed
• Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi — Completed
• Carepartner Collaborative Integrated Therapy Gait (CARE-CITE-Gait) Program — Completed
• Feasibility of EnChroma Use in the Emergency Department Setting — Stopped early
• Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors — Completed
• Carepartner Collaborative Integrated Therapy in Sub-Acute Stroke — Completed
• A Phase 2 Study of RO7490677 In Participants With Myelofibrosis — Completed
• Xenform Postmarket Surveillance Study — Completed
• Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) — Completed
• Ruxolitinib Prior to Transplant in Patients With Myelofibrosis — Stopped early
• Correlative Biomarker Study in Patients With Myeloproliferative Disorders — Completed
• Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction — Stopped early
• Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study) — Completed
• Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) — Completed
• Melatonin and the Metabolic Syndrome — Completed
• Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2) — Completed
• Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries — Completed